Aquestive Therapeutics, Inc. Asset Retirement Obligation, Liabilities Incurred
Aquestive Therapeutics, Inc. (AQST) reported Asset Retirement Obligation, Liabilities Incurred of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes
us-gaap:AssetRetirementObligationLiabilitiesIncurred · last filed 2026-08-11
- Aquestive Therapeutics, Inc. asset retirement obligation, liabilities incurred for the quarter ending 2026-06-30 was $0.00.
- Aquestive Therapeutics, Inc. asset retirement obligation, liabilities incurred for the quarter ending 2026-03-31 was $0.00.
- Aquestive Therapeutics, Inc. asset retirement obligation, liabilities incurred for the quarter ending 2025-06-30 was $0.00.
- Aquestive Therapeutics, Inc. asset retirement obligation, liabilities incurred for the quarter ending 2025-03-31 was $0.00.
- Aquestive Therapeutics, Inc. asset retirement obligation, liabilities incurred for fiscal 2025 was $0.00.
- Aquestive Therapeutics, Inc. asset retirement obligation, liabilities incurred for fiscal 2024 was $0.00.
- Aquestive Therapeutics, Inc. asset retirement obligation, liabilities incurred for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Aquestive Therapeutics, Inc. asset retirement obligation, liabilities incurred for fiscal 2022 was $110.00K.
| Period end | Asset Retirement Obligation, Liabilities Incurred 3 month | Asset Retirement Obligation, Liabilities Incurred 6 month | Asset Retirement Obligation, Liabilities Incurred 12 month |
|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-11 | $0.00 derived: sum of 2 quarters · filed 2026-08-11 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-08-11 | ||
| 2025-12-31 | $0.00 10-K · filed 2026-03-04 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-11 | $0.00 derived: sum of 2 quarters · filed 2026-08-11 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-08-11 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-03-04 | ||
| 2023-12-31 | $0.00 10-K · filed 2025-03-05 | ||
| 2022-12-31 | $110.00K 10-K · filed 2024-03-05 | ||
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 | ||
| 2020-12-31 | $0.00 10-K · filed 2022-03-08 | ||
| 2019-12-31 | $0.00 10-K · filed 2021-03-09 | ||
| 2018-12-31 | $5.00K 10-K · filed 2020-03-11 | ||
| 2017-12-31 | $0.00 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |